Persistent Asset Partners LTD Replimune Group, Inc. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Replimune Group, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 7,492 shares of REPL stock, worth $76,793. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,492
Previous 17,143
56.3%
Holding current value
$76,793
Previous $167 Million
58.36%
% of portfolio
0.05%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
196Shares Held
77.6MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$113 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$111 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$48.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$47.8 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$40.1 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $505M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...